# Chronic Graft-versus-host Disease (cGvHD) Prophylaxis With or Without ATG Prior to Stem Cell Transplantation (SCT) From HLA-identical Siblings in Patients With Acute Leukemia

> **NCT00678275** · PHASE3 · COMPLETED · sponsor: **Universitätsklinikum Hamburg-Eppendorf** · enrollment: 161 (actual)

## Conditions studied

- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia

## Interventions

- **DRUG:** ATG FRESENIUS (Anti-Lymphocyte-Globulin)
- **DRUG:** ATG FRESENIUS (Anti-Lymphocyte-Globulin)

## Key facts

- **NCT ID:** NCT00678275
- **Lead sponsor:** Universitätsklinikum Hamburg-Eppendorf
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2014-02
- **Final completion:** 2015-03
- **Target enrollment:** 161 (ACTUAL)
- **Last updated:** 2015-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00678275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00678275, "Chronic Graft-versus-host Disease (cGvHD) Prophylaxis With or Without ATG Prior to Stem Cell Transplantation (SCT) From HLA-identical Siblings in Patients With Acute Leukemia". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00678275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*